View in EDS

Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

Saved in:
Bibliographic Details
Title: Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.
Authors: Lu DR; Amgen Inc. South San Francisco, CA United States., Osgood T; Amgen Inc. Thousand Oaks, CA United States., Ma S; Amgen Inc. South San Francisco, CA United States., Zhang H; Amgen Inc. South San Francisco, CA United States., Kanke M; Amgen (United States) South San Franciso United States., Tan JA; Amgen (United States) South San Francisco, CA United States., Paudel SN; Amgen Inc. Thousand Oaks, CA United States., Zhou H; Amgen (United States) South San Francisco, CA United States., Estrada J; Amgen Inc. Thousand Oaks, CA United States., Yamawaki T; Amgen Inc. South San Francisco, CA United States., Tarbell K; Amgen Inc. South San Francisco, CA United States., Rex K; Amgen Inc. Thousand Oaks, CA United States., DeVoss J; Amgen (United States) South San Francisco, CA United States., Martin S; Amgen Inc. South San Francisco, CA United States., Wang S; Amgen Inc. South San Francisco, CA United States., Canon J; Amgen Inc. Thousand Oaks, CA United States., Lipford JR; Amgen (United States) United States., Coxon A; Amgen Inc. Thousand Oaks, CA United States., Li CM; Amgen (United States) South San Francisco, CA United States.
Source: Cancer immunology research [Cancer Immunol Res] 2026 Jul 03. Date of Electronic Publication: 2026 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-25-0794